Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for Alcohol
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Oral Presentations
Abstract Number: 15
IMPROVED ALCOHOL USE DISORDER TREATMENT LEADING TO DECREASED READMISSION RATES
SHM Converge 2024
Background: Affecting approximately 5.9% of the US population, alcohol use disorder (AUD) has been established as a prevalent disease in this country (1). Through repeated hospital admissions for alcohol use disorder (including alcohol withdrawal syndromes), hospital costs have steadily risen to recent estimates of 7.6 billion dollars in 2017 (2). Without the establishment of outpatient [...]
Abstract Number: 145
COMPARISON OF PHENOBARBITAL AND LORAZEPAM PROTOCOLS FOR INPATIENT ALCOHOL WITHDRAWAL SYNDROME; A RETROSPECTIVE COHORT STUDY
SHM Converge 2024
Background: Alcohol use disorder (AUD) Is present in 10% of adults and its prevalence is increasing. When patients with AUD are admitted to the hospital, half develop alcohol withdrawal syndrome (AWS), which can cause delirium, hallucinations, seizures, and even mortality if not treated appropriately. A fixed-dose phenobarbital strategy may be superior to the standard of [...]
Abstract Number: 226
ALCOHOL USE DISORDER AND THE INPATIENT TREATMENT LANDSCAPE
SHM Converge 2024
Background: Alcohol use disorder (AUD) is a pervasive disease affecting 28.6 million (11.3%) American adults in 2021.1 Medications for AUD (MAUD), including naltrexone, acamprosate, and disulfiram, are effective, yet less than 5% of these patients received treatment.1,2    Inpatient encounters of patients with AUD present a crucial opportunity to initiate MAUD, prompting this quality improvement [...]
Abstract Number: 277
MEDICATIONS FOR AUD AND DISCHARGE FOLLOW-UP AFTER INPATIENT ALCOHOL DETOXIFICATION
SHM Converge 2024
Background: Alcohol withdrawal is a common reason for admission to acute care hospitals. The American Society of Addiction Medicine (ASAM) has proposed that prescription of medications for alcohol use disorder (AUD) and timely outpatient follow-up are important quality measures for inpatient detoxification, but few studies report the frequency of AUD medications and subsequent follow-up for [...]
Abstract Number: 405
SCREENING AND TREATMENT OF UNHEALTHY ALCOHOL USE DURING ACUTE HOSPITALIZATION
SHM Converge 2024
Background: Between 5-30% of hospitalized patients screen positive for unhealthy alcohol use (UAU), and roughly 10-15% of patients have alcohol use disorder (AUD). Brief counseling and medications for AUD are shown to reduce alcohol consumption yet are underutilized in hospitals: over 90% of patients nationally are not screened and treated for UAU. Purpose: To increase [...]
Abstract Number: 651
PANCREATIC PUZZLES: HEMOSUCCUS PANCREATICUS FROM A BLEEDING PANCREATIC HEAD PSEUDOANEURYSM
SHM Converge 2024
Case Presentation: A 58-year-old male with a history of alcohol use disorder, recurrent and chronic pancreatitis and a recently identified 2.7cm pancreatic head pseudocyst on a prior admission, presented with abdominal pain and melena. CT scan of the abdomen and pelvis with contrast demonstrated extravasation of contrast into the duodenal lumen. A CT GI bleed [...]
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top